2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow HTLV-I Infection: new trials by email Literature Review of HTLV-I Infection trials Research Report on HTLV-I Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-Tac for Treatment of Leukemia daclizumab - HTLV-I Infection, T Cell Leukemia | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 34 | 1999-12-01 | 2012-08-20 |
| Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM) Recombinant human interferon beta-1a - HTLV-I Infection, Spinal Cord Disease | Phase 2 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 12 | 1998-09-01 | 2008-03-04 |
HTLV-I Infections (2) · Diabetes Mellitus, Insulin-Dependent, 10 (1) · Leukemia, T-Cell (1) · Leukemia-Lymphoma, Adult T-Cell (1) · Paraparesis, Tropical Spastic (1) · Spinal Cord Diseases (1) · Virus Diseases (1)
Deltaretrovirus Infections (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Infections (2) · RNA Virus Infections (2) · Retroviridae Infections (2) · Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1)
Daclizumab (1)
National Cancer Institute (NCI) (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1)
United States (2)